Keyphrases
Hepatitis B Virus
100%
Catalytic Subunit
100%
Enzyme Catalysis
100%
Virus Persistence
100%
Hypoxia-inducible factor-1α (HIF-1α)
100%
RelB
100%
Apolipoprotein B mRNA Editing Enzyme
100%
Immune Response
16%
Knockdown
16%
Hepatitis B Surface Antigen (HBsAg)
16%
Chronic HBV
16%
Immunohistochemistry
8%
Quantitative PCR
8%
In Situ Hybridization
8%
Immune Activation
8%
Inflammation
8%
Aryl Hydrocarbon Receptor
8%
Liver
8%
Hypoxia
8%
Therapeutic Strategies
8%
Mass Spectrometry
8%
Oxygenation
8%
Immune System
8%
Immunocytochemistry
8%
Antiviral Activity
8%
Liver Biopsy
8%
Covalently Closed Circular DNA
8%
HepaRG
8%
Chronic Hepatitis
8%
Immune Therapy
8%
Chromatin Immunoprecipitation (ChIP)
8%
DNA Decay
8%
Cytidine Deaminase
8%
Restriction Factor
8%
Subsequent Effects
8%
Immunoblotting
8%
HIF-2
8%
Viral Oncogenes
8%
Reticuloendotheliosis
8%
Dysregulated Immune Response
8%
Active Patient
8%
Hepatitis B Core-related Antigen
8%
Immune Active
8%
Biochemistry, Genetics and Molecular Biology
down Regulation
100%
Enzyme Active Site
100%
Hypoxia Inducible Factor 1
100%
Hepatitis B Virus
100%
Apolipoprotein B
100%
Messenger RNA
100%
Immunity
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Chromatin Immunoprecipitation
8%
Immune Response
8%
Mass Spectrometry
8%
Agonist
8%
Oxygenation
8%
Upregulation
8%
Aryl Hydrocarbon Receptor Nuclear Translocator
8%
Virus Oncogene
8%
HBcAg
8%
Immunocytochemistry
8%
Cytidine Deaminase
8%
In Situ Hybridization
8%
Immunoblotting
8%
Immunology and Microbiology
down Regulation
100%
Enzyme Active Site
100%
Hypoxia Inducible Factor 1
100%
Hepatitis B Virus
100%
Immunity
33%
Western Blot
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
HBcAg
8%
Agonist
8%
Immune System
8%
Immune Response
8%
Upregulation
8%
Chromatin Immunoprecipitation
8%
Hypoxia Inducible Factor 1beta
8%
Virus Oncogene
8%
Oxygenation
8%
Immunotherapy
8%
Immunocytochemistry
8%
In Situ Hybridization
8%